The European Parliament’s Special Committee on Beating Cancer (BECA) has officially adopted its own initiative (INI) report on how to strengthen the EU’s role in the fight against cancer.
This is an important news for in silico medicine community because the report’s final compromise amendments include modelling and artificial intelligence as opportunities to minimise patient risk in clinical trials as well as to be more cost effective. The report is extremely supportive of digital innovations and their potential to improve cancer care. It adds to the legislative evidence base in support of modelling and simulation as a crucial healthcare tool.
The Parliament is expected to vote on the report on 14 February 2022, at which point the report will be fully adopted.
HERE you can find all the details of the BECA program.